Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Incyte Corporation
Incyte Corporation
Incyte Corporation
Prelude Therapeutics
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Chicago
Stanford University
Mayo Clinic
Hangzhou GluBio Pharmaceutical Co., Ltd.
AbbVie
City of Hope Medical Center
American Regent, Inc.
University of Virginia
University of Alabama at Birmingham
Cellenkos, Inc.
Icahn School of Medicine at Mount Sinai